Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

RAP media thread., page-2942

First 2942 Last

Share
Profile

Follow
pilko3

6,758 Posts.

858

14/04/22

07:58

Post #: 60845615
Share

Originally posted by chksalad: ↑

An illuminating interview with Alodokter's co-founder and an Operations Head doctor.

Cough Test, Health Technology Innovation in Alodokter Application (akurat.co)

You will need to click the "Translate page from Indonesian button" which pops up as the original article is in Bahasa Indonesian.

The last paragraph is prophetic as it alludes to the ResApp technology being used for the COVID-19 test which is why Pfizer is particularly interested in the company and is a massive validation of the technology.

Despite the "rockstar" nature of the COVID-19 screening test, don't forget the "bread and butter" aspect of the ResAppDX diagnostic tests which in places like Indonesia (270 million people or 10 times Australia's population) will grow rapidly in its use and acceptance. COVID-19 is the headline news now and the foreseeable future, but ResAppDX will still be the backbone anchoring the company for patient diagnosis, monitoring and management.

Also much has already been said, discussed and debated as to why the BOD approved the the Pfizer takeover. My thoughts are that it served 4 purposes:-

1. Commit one entity to put some $$$ on the table
2. Bring the eyes of the world, and especially other interested parties who have been sitting on the fence with the free publicity it generates.
3. Draw in alternative suitors and partners
4. Solve the short term CR funding issue by getting Pfizer's $3M ($4M with enrolment milestone) which in most likelihood was tied to the BOD approval of the takeover bid.

Lastly, the fate of the company is in the shareholders hands to approve the takeover, not the BOD. Maybe, they did have some brains after all, contrary to some opinions.

Expand

Biden Marches Out COVID Jab Boosters Despite Concerns (mercola.com)
Eye opening discussion re FDA, Pfizer, Covid Info etc...well worth watching. It gives damning info as to how the lies and trials and regulators and Pharma (Pfizer in particular) continue to operate with impunity. Here is more evidence re the company RAP is going into business with...for better or for worse. Make up your own minds and DYOR.
Gotta be a NO vote...just has to be!

RAP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

AI stocks: What to expect in 2024-25

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions